Abiopharma

🔍 Ryan Paul D (Director)

Company: Fox Corp (FOX)

Report Date: 2026-03-25

Detailed Transactions and Holdings:

• Acquired 126 shares of Deferred Stock Units (Derivative)
  Date: 2026-03-25 | Code: A | equity_swap_involved: 0 | shares_owned_after: 26,966.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3, F3, F4

Footnotes:

• F1: Each deferred stock unit represents the equivalent of one share of Fox Corporation's Class A Common Stock.
• F2: Represents dividend equivalents accrued with respect to deferred stock units.
• F3: The deferred stock units representing dividend equivalents become payable in stock upon the pay out of the underlying deferred stock units. The reported deferred stock units become payable on the earlier of (i) the first trading day of the quarter five years following the grant and (ii) the Reporting Person's end of service as a Director.
• F4: Represents the aggregate number of deferred stock units held by the Reporting Person, including dividend equivalents accrued that vest on the same terms as the respective underlying deferred stock units.